Kashmiri political activist and Director of the European Foundation for South Asian Studies (EFSAS), Junaid Qureshi, voiced deep concern over the growing radicalisation among educated youth in Jammu ...

Investors might want to bet on Bilibili (BILI), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Investors in Bilibili Inc (Symbol: BILI) saw new options become available today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BILI ...

Bilibili (BILI) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.08 per share a year ago. These figures are ...

Bilirubin is a yellowish substance created by the breakdown of red blood cells. Detecting it in your urine can be a sign of a health problem, such as liver or gallbladder disease. The detection of ...

We recently published a list of These 10 Stocks Are Flying High. In this article, we are going to take a look at where Bilibili Inc. (NASDAQ:BILI) stands against other best-performing stocks on ...

Bilibili delivered strong Q1 results with revenue and profit exceeding expectations, driven by robust growth across all key business segments and improving operating metrics. The platform's ...

If a recent blood test shows elevated bilirubin levels, there’s a chance you could have a common and generally harmless genetic condition known as Gilbert Syndrome, which is pronounced “Jill-bear,” ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Bili, which will be on the stage ...

Shares of Bilibili fell 5.5% Thursday. Chinese equities faced headwinds following the release of disappointing economic data and intensifying geopolitical concerns. Get access to the leaderboards ...